Galectin-9 is increased in several hematologic neoplasia, including chronic lymphocytic leukemia [64], cutaneous T cell lymphoma, and acute myeloid leukemia (AML) [65]. Here, LGALS9 is linked to B-cell chronic lymphocytic leukemia.